The Use of Interleukin-6 Inhibitors in Patients with Coronavirus Disease 2019 Who Develop Acute Kidney Injury
Main Authors: | Chia Siang Kow, Syed Shahzad Has, Dinesh Sangarran Ramachandram |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2022-10-01
|
Series: | Turkish Journal of Nephrology |
Online Access: | https://turkjnephrol.org/en/the-use-of-interleukin-6-inhibitors-in-patients-with-coronavirus-disease-2019-who-develop-acute-kidney-injury-137087 |
Similar Items
-
Favipiravir and hyperuricemia in patients with COVID-19—suggestions for future studies
by: Chia Siang Kow, et al.
Published: (2023-09-01) -
The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19 mortality in patients with diabetes: A systematic review and meta‐analysis
by: Chia Siang Kow, et al.
Published: (2023-09-01) -
Coenzyme Q10 therapy in patients with post COVID-19 condition
by: Chia Siang Kow, et al.
Published: (2023-02-01) -
Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
by: Chia Siang Kow, et al.
Published: (2020-11-01) -
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials
by: Chia Siang Kow, et al.
Published: (2022-02-01)